Harvard Bioscience Operating Income 2010-2024 | HBIO

Harvard Bioscience operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Harvard Bioscience Annual Operating Income
(Millions of US $)
2024 $-6
2023 $2
2022 $-7
2021 $2
2020 $0
2019 $0
2018 $1
2017 $-1
2016 $-3
2015 $-2
2014 $7
2013 $2
2012 $8
2011 $8
2010 $10
2009 $8
Harvard Bioscience Quarterly Operating Income
(Millions of US $)
2024-12-31 $0
2024-09-30 $-2
2024-06-30 $-2
2024-03-31 $-2
2023-12-31 $0
2023-09-30 $-1
2023-06-30 $1
2023-03-31 $2
2022-12-31 $0
2022-09-30 $-4
2022-06-30 $4
2022-03-31 $-7
2021-12-31 $2
2021-09-30 $1
2021-06-30 $0
2021-03-31 $0
2020-12-31 $3
2020-09-30 $0
2020-06-30 $1
2020-03-31 $-3
2019-12-31 $2
2019-09-30 $-1
2019-06-30 $0
2019-03-31 $0
2018-12-31 $2
2018-09-30 $1
2018-06-30 $0
2018-03-31 $-1
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $-1
2016-09-30 $-1
2016-06-30 $-1
2016-03-31 $0
2015-12-31 $0
2015-09-30 $-1
2015-06-30 $0
2015-03-31 $-1
2014-12-31 $2
2014-09-30 $1
2014-06-30 $2
2014-03-31 $1
2013-12-31 $-1
2013-09-30 $0
2013-06-30 $1
2013-03-31 $1
2012-12-31 $5
2012-09-30 $0
2012-06-30 $1
2012-03-31 $1
2011-12-31 $4
2011-09-30 $0
2011-06-30 $3
2011-03-31 $2
2010-12-31 $3
2010-09-30 $2
2010-06-30 $2
2010-03-31 $3
2009-12-31 $3
2009-09-30 $2
2009-06-30 $1
2009-03-31 $2
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.015B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.687B 15.97
Kewaunee Scientific (KEQU) United States $0.107B 7.49